Izumi, Japan

Kenji Nakamura

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Nakamura. Retrieved from https://idiyas.com/inventor/kenji-nakamura-92p2bcv2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenji Nakamura: Innovator in Controlled-Release Drug Delivery

Introduction

Kenji Nakamura is a notable inventor based in Izumi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release drug formulations. His innovative work aims to enhance the efficacy and safety of drug delivery systems.

Latest Patents

Nakamura holds a patent for a controlled-release composition. This composition comprises a drug-containing core that is coated with a coating composition. The coating contains a water-insoluble substance and a swellable polymer that lacks basic groups. This unique formulation is designed to maintain an almost constant drug concentration in plasma over an extended period, ensuring sustained drug action in the body.

Career Highlights

Kenji Nakamura is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on innovative drug delivery systems that improve patient outcomes. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Yohko Akiyama and Eiji Nara. Their collaborative efforts have further enhanced the research and development initiatives at Takeda.

Conclusion

Kenji Nakamura's contributions to controlled-release drug delivery systems exemplify the importance of innovation in pharmaceuticals. His work not only advances medical science but also improves the quality of life for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…